Resumen
.
Citas
1 Goulart IMB, Arbex GL. Adverse effects of multidrug therapy in leprosy patients a five year survey at a Health Center of the Federal University of Uberlândia. Revista da Sociedade Brasileira de Medicina Tropical 2002; 35(5): 453-60.
2 Kraemer T, Paul LD, Jochum CH, Maurer HH. Acute poisoning with dapsone, a case report. Toxichem Krintech 2002; (69):80–5.
3 Turner MD, Karlis V, Glickman RS. The recognition, phisiology, and treatment of medication induced methemoglobinemia: a case report. Anesth Prog 2007; (54): 115-7.
4 Prasad R, Das BP, Singh R, Sharma KK. Dapsone induced methemoglobinemia, sulfhemoglobinemia and hemolytic anemia: a case report with note on treatment strategies. Ind J Pharm 2002; (34): 283–5.
5 Woodhouse KW, Henderson DB, Charlton B, Peaston RT, Rawlins MD. Acute dapsone poisoning: clinical features and pharmacokinetic studies. Hum Toxicol 1983 (2): 507–10.
6 Elonen E, Neuvonen PJ, Halmekoski J, Mattila MJ. Acute dapsone intoxication: a case with prolonged symptoms. Clin Toxicol 1979; (14): 79–85.
7 Prasad R, Singh R, Mishra OP, Pandey M. Dapsone induced methemoglobinemia: intermittent vs continuos Intravenous Methylene Blue Therapy. Indian Jornaul of Pediatrics 75, março, 2008, 245-247.
8 Dawson AH, Whyte IM. Management of dapsone poisoning complicated by methaemoglobinaemia, Med Toxicol Adverse Drug Exp 4 1989: 387–92.
9 Shadnia S, Rahimi M, Moeinsadat G, Vesal M. Donyavi and M. Abdollahi, acute methemoglobinemia following attempted suicide by dapson, Archives of Medical Research 2006 (37):410-14.
10 Nancy E. Methemoglobinemia. Journal of Emergency Nursing 2007; (3): 172-74.11 Graham Jr WR. Adverse effects of dapsone. Int J Dermatol 1975; 14 (7): 494–500.
12 Emedicine Methemoglobinemia. Available from: http://www.emedicine.com/EMERG/topic313.htm.
2 Kraemer T, Paul LD, Jochum CH, Maurer HH. Acute poisoning with dapsone, a case report. Toxichem Krintech 2002; (69):80–5.
3 Turner MD, Karlis V, Glickman RS. The recognition, phisiology, and treatment of medication induced methemoglobinemia: a case report. Anesth Prog 2007; (54): 115-7.
4 Prasad R, Das BP, Singh R, Sharma KK. Dapsone induced methemoglobinemia, sulfhemoglobinemia and hemolytic anemia: a case report with note on treatment strategies. Ind J Pharm 2002; (34): 283–5.
5 Woodhouse KW, Henderson DB, Charlton B, Peaston RT, Rawlins MD. Acute dapsone poisoning: clinical features and pharmacokinetic studies. Hum Toxicol 1983 (2): 507–10.
6 Elonen E, Neuvonen PJ, Halmekoski J, Mattila MJ. Acute dapsone intoxication: a case with prolonged symptoms. Clin Toxicol 1979; (14): 79–85.
7 Prasad R, Singh R, Mishra OP, Pandey M. Dapsone induced methemoglobinemia: intermittent vs continuos Intravenous Methylene Blue Therapy. Indian Jornaul of Pediatrics 75, março, 2008, 245-247.
8 Dawson AH, Whyte IM. Management of dapsone poisoning complicated by methaemoglobinaemia, Med Toxicol Adverse Drug Exp 4 1989: 387–92.
9 Shadnia S, Rahimi M, Moeinsadat G, Vesal M. Donyavi and M. Abdollahi, acute methemoglobinemia following attempted suicide by dapson, Archives of Medical Research 2006 (37):410-14.
10 Nancy E. Methemoglobinemia. Journal of Emergency Nursing 2007; (3): 172-74.11 Graham Jr WR. Adverse effects of dapsone. Int J Dermatol 1975; 14 (7): 494–500.
12 Emedicine Methemoglobinemia. Available from: http://www.emedicine.com/EMERG/topic313.htm.

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Descargas
Los datos de descargas todavía no están disponibles.